Vyome Biosciences, a dermatology based innovative bio-pharmaceutical company, which is pioneering the development of next generation antibiotics and antifungal agents...
Read moreBristol-Myers Squibb Company announced results from a 7-year, long-term follow-up from a prospective, randomized Phase III trial (BENEFIT) in kidney...
Read moreThe Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015, in Las Vegas. Doug Manion,...
Read moreToday announced that primary endpoints were successfully met in ALLY-1, a Phase III clinical trial evaluating a 12-week regimen of...
Read moreThe US Food and Drug Administration (FDA) recently announced that fixed-combination drugs (FCD) comprised of at least one NCE will...
Read moreReading Scientific Services (RSSL) has doubled the number of course places on offer after experiencing significant increases in the number...
Read moreNovartis has received approval from the US Food and Drug Administration (FDA) for its Jadenu (deferasirox) tablets to treat patients...
Read moreMicromeritics' Instrument Grant Committee has recently selected its latest grant recipient. A TriStar II Plus 3030, NanoPlus 3 and Flowprep...
Read moreMicromeritics' Instrument Grant Committee has recently selected its latest grant recipient. A 3Flex Surface Characterisation Analyser was awarded to the...
Read moreReading Scientific Services (RSSL) will launch a new suite of flavour services in April, which include sophisticated flavour analysis. Analysis...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.